Alps Group Inc (ALPS)
NASDAQ: ALPS · Real-Time Price · USD
0.4778
+0.0328 (7.37%)
Jul 17, 2026, 3:28 PM EDT - Market open
Alps Group Market Cap
Alps Group has a market cap or net worth of $79.51 million as of July 17, 2026. Its market cap has increased by 81.77% in one year.
Market Cap
79.51M
Enterprise Value
80.07M
1-Year Change
81.77%
Ranking
Category
Stock Price
$0.48
ChartMarket Cap Chart
Since December 23, 2021, Alps Group's market cap has decreased from $143.00M to $79.51M, a decrease of -44.40%. That is a compound annual growth rate of -12.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 79.51M | -45.04% |
| Dec 31, 2025 | 144.67M | 230.19% |
| Dec 30, 2024 | 43.81M | -50.64% |
| Dec 29, 2023 | 88.76M | -41.77% |
| Dec 30, 2022 | 152.44M | 6.93% |
| Dec 30, 2021 | 142.56M | -0.30% |
| Dec 23, 2021 | 143.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rani Therapeutics Holdings | 83.87M |
| Telomir Pharmaceuticals | 83.22M |
| Heron Therapeutics | 83.09M |
| Acrivon Therapeutics | 82.18M |
| Champions Oncology | 80.27M |
| LeonaBio | 80.13M |
| Gossamer Bio | 79.05M |
| OKYO Pharma | 78.19M |